MetLife Investment Management, LLC - 03 Jun 2022 Form 4 Insider Report for Neuberger Berman High Yield Strategies Fund Inc. (NHS)

Role: 10%+ Owner
Signature: /s/ Israel Grafstein, Chief Compliance Officer of MetLife Investment Management, LLC
Issuer symbol: NHS
Transactions as of: 03 Jun 2022
Net transactions value: +$702,250,000,000,000
Form type: 4
Filing time: 07 Jun 2022, 16:19:35 UTC
Previous filing: 26 May 2022
Next filing: 04 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NHS	Floating Rate Senior Note, Series B Note, Due Sep. 18, 2023	Purchase	$702,250,000,000,000	+26,500,000		$26500000.00^*	$26,500,000	03 Jun 2022	See Footnotes	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This price reflects the aggregate principal amount of the Floating Rate Senior Note, Series B Note, due September 18, 2023 (the "Notes") purchased.
F2	These Notes are held directly by a client for whom the Reporting Person serves as investment manager.
F3	The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.